Mechanism of HIV-1 Tat RNA translation and its activation by the Tat protein

Retrovirology

Volumn 6, Issue , 2009, Pages 74-

  Charnay, Nicolas ^a   Ivanyi Nagy, Roland ^a   Soto Rifo, Ricardo ^a   Ohlmann, Théophile ^a   López Lastra, Marcelo ^b   Darlix, Jean Luc ^a  

^a UNIVERSITÉ DE LYON   (France)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LUCIFERASE; TRANSACTIVATOR PROTEIN; VIRUS RNA;

ARTICLE; BIOSYNTHESIS; CELL LINE; GENE FUSION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; REPORTER GENE; VIRUS REPLICATION;

ARTIFICIAL GENE FUSION; BETA-GALACTOSIDASE; CELL LINE; GENE PRODUCTS, TAT; GENES, REPORTER; HIV-1; HUMANS; LUCIFERASES; PROTEIN BIOSYNTHESIS; RNA, VIRAL; VIRUS REPLICATION;

EID: 70349923932     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-74     Document Type: Article

References (59)

1. Strebel K. Virus-host interactions: role of HIV proteins Vif, Tat, and Rev. AIDS 2003, 17(Suppl 4):S25-34. 10.1097/00002030-200317004-00003, 15080177.
2. Cullen BR. Regulation of HIV-1 gene expression. FASEB J 1991, 5:2361-2368.
3. Jeang KT, Xiao H, Rich EA. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem 1999, 274:28837-28840. 10.1074/jbc.274.41.28837, 10506122.
4. Gatignol A. Transcription of HIV: Tat and cellular chromatin. Adv Pharmacol 2007, 55:137-159. full_text, 17586314.
5. Gautier VW, Gu L, O'Donoghue N, Pennington S, Sheehy N, Hall WW. In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 2009, 6:47. 10.1186/1742-4690-6-47, 2702331, 19454010.
6. Chun RF, Jeang KT. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J Biol Chem 1996, 271:27888-27894. 10.1074/jbc.271.44.27888, 8910388.
7. Kashanchi F, Piras G, Radonovich MF, Duvall JF, Fattaey A, Chiang CM, Roeder RG, Brady JN. Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature 1994, 367:295-299. 10.1038/367295a0, 8121496.
8. Marzio G, Tyagi M, Gutierrez MI, Giacca M. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci USA 1998, 95:13519-13524. 10.1073/pnas.95.23.13519, 24851, 9811832.
9. Okamoto H, Sheline CT, Corden JL, Jones KA, Peterlin BM. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc Natl Acad Sci USA 1996, 93:11575-11579. 10.1073/pnas.93.21.11575, 38099, 8876177.
10. Parada CA, Roeder RG. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 1996, 384:375-378. 10.1038/384375a0, 8934526.
11. Veschambre P, Roisin A, Jalinot P. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB. J Gen Virol 1997, 78(Pt 9):2235-2245.
12. Braddock M, Thorburn AM, Chambers A, Elliott GD, Anderson GJ, Kingsman AJ, Kingsman SM. A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction. Cell 1990, 62:1123-1133. 10.1016/0092-8674(90)90389-V, 2205397.
13. SenGupta DN, Berkhout B, Gatignol A, Zhou AM, Silverman RH. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1990, 87:7492-7496. 10.1073/pnas.87.19.7492, 54773, 2120701.
14. Braddock M, Powell R, Blanchard AD, Kingsman AJ, Kingsman SM. HIV-1 TAR RNA-binding proteins control TAT activation of translation in Xenopus oocytes. FASEB J 1993, 7:214-222.
15. Wu Y. HIV-1 gene expression: lessons from provirus and non-integrated DNA. Retrovirology 2004, 1:13. 10.1186/1742-4690-1-13, 449739, 15219234.
16. Sonenberg N, Hinnebusch AG. New modes of translational control in development, behavior, and disease. Mol Cell 2007, 28:721-729. 10.1016/j.molcel.2007.11.018, 18082597.
17. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 2005, 6:318-327. 10.1038/nrm1618, 15803138.
18. Bushell M, Sarnow P. Hijacking the translation apparatus by RNA viruses. J Cell Biol 2002, 158:395-399. 10.1083/jcb.200205044, 2173839, 12163463.
19. Clemens MJ. Translational control in virus-infected cells: models for cellular stress responses. Semin Cell Dev Biol 2005, 16:13-20. 10.1016/j.semcdb.2004.11.011, 15659335.
20. Jackson RJ, Kaminski A. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1995, 1:985-1000. 1369335, 8595564.
21. Kean KM. The role of mRNA 5'-noncoding and 3'-end sequences on 40S ribosomal subunit recruitment, and how RNA viruses successfully compete with cellular mRNAs to ensure their own protein synthesis. Biol Cell 2003, 95:129-139. 10.1016/S0248-4900(03)00030-3, 12867078.
22. Gebauer F, Hentze MW. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 2004, 5:827-835. 10.1038/nrm1488, 15459663.
23. Mazumder B, Seshadri V, Fox PL. Translational control by the 3'-UTR: the ends specify the means. Trends Biochem Sci 2003, 28:91-98. 10.1016/S0968-0004(03)00002-1, 12575997.
24. Pickering BM, Willis AE. The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol 2005, 16:39-47. 10.1016/j.semcdb.2004.11.006, 15659338.
25. Kozak M. The scanning model for translation: an update. J Cell Biol 1989, 108:229-241. 10.1083/jcb.108.2.229, 2115416, 2645293.
26. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999, 68:913-963. 10.1146/annurev.biochem.68.1.913, 10872469.
27. Prevot D, Darlix JL, Ohlmann T. Conducting the initiation of protein synthesis: the role of eIF4G. Biol Cell 2003, 95:141-156. 10.1016/S0248-4900(03)00031-5, 12867079.
28. Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988, 334:320-325. 10.1038/334320a0, 2839775.
29. Jang SK, Krausslich HG, Nicklin MJ, Duke GM, Palmenberg AC, Wimmer E. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988, 62:2636-2643. 253694, 2839690.
30. Jackson RJ, Hunt SL, Gibbs CL, Kaminski A. Internal initiation of translation of picornavirus RNAs. Mol Biol Rep 1994, 19:147-159. 10.1007/BF00986957, 7969103.
31. Vagner S, Galy B, Pyronnet S. Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep 2001, 2:893-898. 10.1093/embo-reports/kve208, 1084086, 11600453.
32. Ali IK, McKendrick L, Morley SJ, Jackson RJ. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G. J Virol 2001, 75:7854-7863. 10.1128/JVI.75.17.7854-7863.2001, 115028, 11483729.
33. Bonnal S, Boutonnet C, Prado-Lourenco L, Vagner S. IRESdb: the Internal Ribosome Entry Site database. Nucleic Acids Res 2003, 31:427-428. 10.1093/nar/gkg003, 165450, 12520041.
34. Berlioz C, Darlix JL. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J Virol 1995, 69:2214-2222. 188890, 7884868.
35. Ricci EP, Soto Rifo R, Herbreteau CH, Decimo D, Ohlmann T. Lentiviral RNAs can use different mechanisms for translation initiation. Biochem Soc Trans 2008, 36:690-693. 10.1042/BST0360690, 18631141.
36. Ohlmann T, Lopez-Lastra M, Darlix JL. An internal ribosome entry segment promotes translation of the simian immunodeficiency virus genomic RNA. J Biol Chem 2000, 275:11899-11906. 10.1074/jbc.275.16.11899, 10766817.
37. Nicholson MG, Rue SM, Clements JE, Barber SA. An internal ribosome entry site promotes translation of a novel SIV Pr55(Gag) isoform. Virology 2006, 349:325-334. 10.1016/j.virol.2006.01.034, 16494914.
38. Herbreteau CH, Weill L, Decimo D, Prevot D, Darlix JL, Sargueil B, Ohlmann T. HIV-2 genomic RNA contains a novel type of IRES located downstream of its initiation codon. Nat Struct Mol Biol 2005, 12:1001-1007.
39. Buck CB, Shen X, Egan MA, Pierson TC, Walker CM, Siliciano RF. The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J Virol 2001, 75:181-191. 10.1128/JVI.75.1.181-191.2001, 113911, 11119587.
40. Brasey A, Lopez-Lastra M, Ohlmann T, Beerens N, Berkhout B, Darlix JL, Sonenberg N. The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J Virol 2003, 77:3939-3949. 10.1128/JVI.77.7.3939-3949.2003, 150645, 12634354.
41. Ronfort C, De Breyne S, Sandrin V, Darlix JL, Ohlmann T. Characterization of two distinct RNA domains that regulate translation of the Drosophila gypsy retroelement. RNA 2004, 10:504-515. 10.1261/rna.5185604, 1370945, 14970395.
42. Balvay L, Lopez Lastra M, Sargueil B, Darlix JL, Ohlmann T. Translational control of retroviruses. Nat Rev Microbiol 2007, 5:128-140. 10.1038/nrmicro1599, 17224922.
43. Jacquenet S, Decimo D, Muriaux D, Darlix JL. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2005, 2:33. 10.1186/1742-4690-2-33, 1180853, 15907217.
44. Soto Rifo R, Ricci EP, Decimo D, Moncorge O, Ohlmann T. Back to basics: the untreated rabbit reticulocyte lysate as a competitive system to recapitulate cap/poly(A) synergy and the selective advantage of IRES-driven translation. Nucleic Acids Res 2007, 35:e121. 10.1093/nar/gkm682, 2094066, 17881372.
45. Peabody DS, Berg P. Termination-reinitiation occurs in the translation of mammalian cell mRNAs. Mol Cell Biol 1986, 6:2695-2703. 367826, 3023945.
46. Geballe AP, Gray MK. Variable inhibition of cell-free translation by HIV-1 transcript leader sequences. Nucleic Acids Res 1992, 20:4291-4297. 10.1093/nar/20.16.4291, 334138, 1354856.
47. Parkin NT, Cohen EA, Darveau A, Rosen C, Haseltine W, Sonenberg N. Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. EMBO J 1988, 7:2831-2837. 457075, 3181141.
48. Kuciak M, Gabus C, Ivanyi-Nagy R, Semrad K, Storchak R, Chaloin O, Muller S, Mely Y, Darlix JL. The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro. Nucleic Acids Res 2008, 36:3389-3400. 10.1093/nar/gkn177, 2425468, 18442994.
49. Hetzer C, Dormeyer W, Schnolzer M, Ott M. Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes Infect 2005, 7:1364-1369. 10.1016/j.micinf.2005.06.003, 16046164.
50. Anderson EC, Lever AM. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J Virol 2006, 80:10478-10486. 10.1128/JVI.02596-05, 1641787, 17041220.
51. Svitkin YV, Pause A, Sonenberg N. La autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNA. J Virol 1994, 68:7001-7007. 237137, 7933082.
52. Hofacker IL, Fekete M, Stadler PF. Secondary structure prediction for aligned RNA sequences. J Mol Biol 2002, 319:1059-1066. 10.1016/S0022-2836(02)00308-X, 12079347.
53. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680. 10.1093/nar/22.22.4673, 308517, 7984417.
54. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003, 31:3406-3415. 10.1093/nar/gkg595, 169194, 12824337.
55. Berkhout B, van Wamel JL. The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure. RNA 2000, 6(2):282-95. 10.1017/S1355838200991684, 1369913, 10688366.
56. Pyronnet S, Dostie J, Sonenberg N. Suppression of cap-dependent translation in mitosis. Genes Dev 2001, 15(16):2083-2093. 10.1101/gad.889201, 312759, 11511540.
57. Thierry S, Marechal V, Rosenzwajg M, Sabbah M, Redeuilh G, Nicolas JC, Gozlan J. Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter. J Virol 2004, 78(22):12198-12206. 10.1128/JVI.78.22.12198-12206.2004, 525107, 15507606.
58. Pyronnet S, Pradayrol L, Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol Cell 2000, 5(4):607-616. 10.1016/S1097-2765(00)80240-3, 10882097.
59. Choudhury I, Wang J, Stein S, Rabson A, Leibowitz MJ. Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1. J Gen Virol 1999, 80(Pt 3):777-782.